(a) Discuss in short the etiology, diagnosis, treatment and complications of cirrhosis of liver. (5+5+5+5=20 marks)

(b) A 15-month-old child brought by the mother with history of 6 episodes of vomiting and 4 episodes of watery diarrhoea was found to

Question

(a) Discuss in short the etiology, diagnosis, treatment and complications of cirrhosis of liver. (5+5+5+5=20 marks)

(b) A 15-month-old child brought by the mother with history of 6 episodes of vomiting and 4 episodes of watery diarrhoea was found to have lethargy and is unable to drink. The child weighed 10 kg before this event of illness.
(i) How would you assess the severity of the illness in this child ?
(ii) Write the fluid management in the first 3 hours.
(iii) Write the treatment guidelines after 3 hours if the child still exhibits signs of dehydration.
(iv) Write the composition and preparation of the WHO Oral Rehydration Salts (ORS). (4+4+4+8=20 marks)

(c) (i) What is the differential diagnosis of psoriatic arthritis ? How would you distinguish psoriatic arthritis from other conditions ?
(ii) Discuss the management of psoriatic arthritis. (5+5=10 marks)

UPSC Answer Check · Accepted Answer

The directive 'discuss' demands a comprehensive, analytical treatment across all sub-parts. Allocate approximately 40% of effort to part (a) on liver cirrhosis (20 marks), 40% to part (b) on pediatric dehydration with its four sub-sections (20 marks), and 20% to part (c) on psoriatic arthritis (10 marks). Structure as: brief introduction acknowledging the clinical spectrum from chronic liver disease to acute pediatric emergency to autoimmune arthritis; systematic body addressing each sub-part with appropriate depth; conclusion emphasizing integrated clinical decision-making and public health relevance of ORS and early arthritis intervention.
- Part (a): Etiology of cirrhosis (viral hepatitis B/C, alcohol, NAFLD, autoimmune, metabolic); diagnosis via Child-Pugh/MELD scoring, imaging, liver biopsy; complications including portal hypertension, variceal bleeding, hepatic encephalopathy, hepatorenal syndrome, HCC; treatment modalities (lifestyle, pharmacological, transplant candidacy)
- Part (b)(i): Assessment using WHO IMCI criteria—lethargy, sunken eyes, skin turgor, inability to drink indicate severe dehydration; weight loss calculation from 10 kg baseline
- Part (b)(ii): First 3 hours fluid management—IV Ringer's Lactate or NS 100 ml/kg for severe dehydration, rapid assessment every 1-2 hours, monitoring for signs of improvement or fluid overload
- Part (b)(iii): Post-3 hour management—reassessment, continued IV fluids if signs persist, transition to oral rehydration when tolerated, zinc supplementation, continued feeding, monitoring for hypoglycemia and electrolyte disturbances
- Part (b)(iv): WHO ORS composition (Na+ 75, K+ 20, Cl- 65, citrate 10, glucose 75 mmol/L; osmolarity 245 mOsm/L); preparation by dissolving one packet in 1 liter clean water; low-osmolarity formula rationale
- Part (c)(i): Differential diagnosis—rheumatoid arthritis (RF/anti-CCP positive, symmetric), ankylosing spondylitis (axial predominance, HLA-B27), reactive arthritis, gout, osteoarthritis; distinguishing features of PsA (dactylitis, enthesitis, nail changes, DIP involvement, asymmetric oligoarthritis)
- Part (c)(ii): Management—NSAIDs for mild disease, DMARDs (methotrexate, sulfasalazine) for peripheral arthritis, biologics (TNF-α inhibitors, IL-17/IL-12/23 inhibitors) for inadequate response; treat-to-target approach, skin-nail psoriasis co-management

Dimension	Weight	Max marks	Excellent	Average	Poor
Concept correctness	20%	10	Demonstrates precise pathophysiological understanding across all parts: cirrhosis staging systems (Child-Pugh, MELD-Na), accurate WHO dehydration classification (no/some/severe), correct ORS electrolyte concentrations, and PsA classification criteria (CASPAR); cites updated WHO 2016 low-osmolarity ORS formulation	Shows generally correct concepts with minor errors—e.g., outdated ORS composition, incomplete MELD components, or conflating some/severe dehydration criteria; understands core ideas but lacks precision in numbers or criteria	Major conceptual errors—e.g., recommending plain water for severe dehydration, incorrect fluid volumes (ml/kg errors), confusing RA with PsA diagnostic criteria, or stating outdated high-osmolarity ORS as current standard
Clinical correlation	20%	10	Integrates clinical reasoning throughout: for (a) links specific etiologies to regional prevalence (HBV in India, alcohol); for (b) applies IMCI protocol to the 15-month-old with weight-based calculations; for (c) correlates nail psoriasis and dactylitis as pathognomonic clinical clues; demonstrates patient-centered decision-making	Mentions clinical features without systematic application; provides correct information but lacks integration—e.g., lists cirrhosis complications without prioritizing by mortality risk, or describes PsA features without emphasizing distinguishing clinical pearls	Purely theoretical or textbook recitation without clinical application; fails to recognize that lethargy + inability to drink = severe dehydration requiring urgent IV fluids; misses weight-based calculations entirely
Diagram / pathway	15%	7.5	Includes well-labeled diagrams: portal circulation with sites of portosystemic collateral formation; ORS glucose-sodium co-transport mechanism; algorithm for pediatric dehydration assessment and fluid therapy; PsA joint distribution pattern (DIP, asymmetric oligoarthritis, axial) with dactylitis illustration	Attempts relevant diagrams with minor errors—e.g., incomplete portal venous anatomy, ORS preparation steps without physiological explanation, or joint distribution without clear labeling; flowcharts present but not optimally structured	No diagrams despite clear visual opportunities; or seriously flawed anatomy/physiology—e.g., incorrect portal vein tributaries, confused co-transport mechanism, missing critical steps in dehydration management algorithm
Differential / staging	20%	10	Systematic differentials with discriminating features: for (a) distinguishes compensated vs. decompensated cirrhosis and Child-Pugh classes; for (b) clearly differentiates no/some/severe dehydration with specific clinical signs; for (c) presents structured CASPAR criteria application and contrasts with RA (serology, joint pattern), AS (axial, uveitis), reactive arthritis (post-infectious)	Lists differential diagnoses without clear distinguishing framework; mentions staging systems but applies inconsistently; recognizes dehydration categories but sign-symptom correlation is incomplete; PsA differential present but lacks systematic comparison points	No meaningful differential or staging; confuses cirrhosis with hepatitis staging, cannot differentiate dehydration severity, or fails to distinguish PsA from RA; omits critical distinguishing features like dactylitis or nail changes
Management / public-health angle	25%	12.5	Comprehensive, evidence-based management with public health relevance: for (a) includes hepatocellular carcinoma surveillance, variceal prophylaxis, transplant evaluation; for (b) emphasizes continued feeding, zinc supplementation, ORS availability under India's diarrhea control program, caregiver education; for (c) treat-to-target strategy, biologic access issues, multidisciplinary care; cites Indian guidelines and WHO protocols	Covers standard treatments without prioritization or public health context; mentions ORS but not national program implementation; includes biologics for PsA without discussing access/cost barriers; acceptable clinical management but narrow perspective	Dangerous or outdated management recommendations—e.g., fluid restriction in cirrhosis without diuretic balance, ORS contraindication in severe dehydration, or exclusive NSAID use for PsA without DMARD/biologic escalation; ignores public health dimensions entirely

Q4

Directive word: Discuss

How this answer will be evaluated

Approach

Key points expected

Evaluation rubric

Practice this exact question

More from Medical Science 2021 Paper II